Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2

Conditions

Prostatic Neoplasms 6268Carcinoma, Renal Cell 1913Urinary Bladder Neoplasms 1670Kidney Neoplasms 930Breast Neoplasms 793Neoplasms 788Carcinoma, Transitional Cell 592Carcinoma, Non-Small-Cell Lung 524Neoplasm Metastasis 510Melanoma 484Ovarian Neoplasms 468Colorectal Neoplasms 454Lung Neoplasms 435Pancreatic Neoplasms 325Testicular Neoplasms 290Stomach Neoplasms 274Sarcoma 266Uterine Cervical Neoplasms 264Non-Muscle Invasive Bladder Neoplasms 263Head and Neck Neoplasms 241Colonic Neoplasms 217Esophageal Neoplasms 203Squamous Cell Carcinoma of Head and Neck 202Carcinoma, Hepatocellular 197Wilms Tumor 196Endometrial Neoplasms 189Recurrence 162Neuroblastoma 148Urologic Neoplasms 147Small Cell Lung Carcinoma 146

Interventions

durvalumab 1Observation 1Gemcitabine 1Cisplatin 1Chemoradiotherapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gallbladder Cancer Unresectable × Genitourinary × Clear all
NCT06591650 2026-05-14

GCND

Fudan University

Phase 2 Recruiting
33 enrolled
GastrointestinalGenitourinary

Gallbladder Cancer Unresectable

NCT05493956 2022-09-09

RACE-GB

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Phase NA Unknown
120 enrolled
GastrointestinalGenitourinary

Gallbladder Cancer Unresectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡